Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
55,348,918
-
Total 13F shares
-
59,584,020
-
Share change
-
+1,692,036
-
Total reported value
-
$2,367,665,644
-
Put/Call ratio
-
41%
-
Price per share
-
$39.73
-
Number of holders
-
173
-
Value change
-
+$56,487,603
-
Number of buys
-
86
-
Number of sells
-
90
Institutional Holders of Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) as of Q3 2025
As of 30 Sep 2025,
Apogee Therapeutics, Inc. - Common Stock, $0.00001 par value (APGE) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,584,020 shares.
The largest 10 holders included
VR ADVISER, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, BlackRock, Inc., VANGUARD GROUP INC, Driehaus Capital Management LLC, Fairmount Funds Management LLC, STATE STREET CORP, and Paradigm Biocapital Advisors LP.
This page lists
173
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.